Spun out of the University of Minnesota, EmboMedics is an early stage medical technology company addressing development of drug loaded and unloaded embolization materials for several Indications to include Uterine Fibroid Embolization (UFE), Trauma, Benign Prostatic Hyperplasia and Transarterial Chemoembolization (TACE). At the core of the firm's endeavors is a new bioresorbable, drug loadable embolic bead technology designed to block blood vessels supplying tumors and then resorb to enable the reuse of those vessels for needed drug delivery.
